We are live on
!
Find out more
FC
Fairpointe Capital Portfolio holdings
AUM
$66.3M
1-Year Est. Return
101.32%
This Fund
S&P 500
This Quarter
Est. Return
+15.88%
1 Year Est. Return
+101.32%
3 Year Est. Return
+48.06%
5 Year Est. Return
+95.29%
10 Year Est. Return
–
AUM
$3B
AUM Growth
+$96.3M
(+3.3%)
Cap. Flow
-$321M
Cap. Flow
% of AUM
-10.7%
Top 10 Holdings %
Top 10 Hldgs %
32.14%
Holding
86
New
2
Increased
20
Reduced
36
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Magna International
MGA
|
+$49.2M |
| 2 |
Wabtec
WAB
|
+$37.3M |
| 3 |
TechnipFMC
FTI
|
+$14.5M |
| 4 |
LGF.A
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
|
+$7.4M |
| 5 |
Bunge Global
BG
|
+$6.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
New York Times
NYT
|
+$44.3M |
| 2 |
Teradata
TDC
|
+$40.7M |
| 3 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$37.7M |
| 4 |
Gerdau
GGB
|
+$36.7M |
| 5 |
Wolfspeed
WOLF
|
+$31.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.45% |
| 2 | Consumer Discretionary | 18.66% |
| 3 | Technology | 15.24% |
| 4 | Communication Services | 14.09% |
| 5 | Consumer Staples | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Ovid Therapeutics
OVID
$427M
| $179K | 0.01% |
101,000
+60,000
| +146% | +$150K |
|
|
APTX
77
DELISTED
Aptinyx Inc. Common Stock
APTX
| $97K | ﹤0.01% |
24,000
| – | – |
|
|
KIN
78
DELISTED
Kindred Biosciences, Inc.
KIN
| $92K | ﹤0.01% |
10,000
| – | – |
|
79
FMC
FMC
$1.25B
| – | – |
-386,405
| Closed | -$24.8M |
|
|
80
Gerdau
GGB
$9.54B
| – | – |
-12,294,185
| Closed | -$36.7M |
|
|
IPG
81
DELISTED
Interpublic Group of Companies
IPG
| – | – |
-338,534
| Closed | -$6.98M |
|
82
iShares Russell Mid-Cap ETF
IWR
$55.9B
| – | – |
-18,700
| Closed | -$869K |
|
83
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
| – | – |
-1,356
| Closed | -$411K |
|
Similar funds
EFM
NI
UL
WSC
AGEC
CIA
FLSMF
OHS
Fairpointe Capital's Q1 2019 Portfolio in Review
As of Q1 2019, Fairpointe Capital held 86 positions worth $3B, up 3.3% from $2.91B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Fairpointe Capital withdrew a net $321M in Q1 2019, closing 5 positions and reducing 36 holdings. Its most notable exit was Gerdau, an estimated $36.7M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Fairpointe Capital opened a new position in ResMed worth $209K.
- Fairpointe Capital's largest Q1 2019 buy was ResMed: 2,010 shares worth $209K.
- Fairpointe Capital added most to Magna International in Q1 2019, an estimated $49.2M increase.
- Fairpointe Capital's biggest Q1 2019 reduction was New York Times, cutting an estimated $44.3M.
- Fairpointe Capital fully exited Gerdau in Q1 2019, selling an estimated $36.7M.
- Fairpointe Capital's ten largest holdings make up 32% of its $3B portfolio in Q1 2019.
- Fairpointe Capital opened 2 new positions and closed 5 in Q1 2019.
- Fairpointe Capital's portfolio value rose 3.3% quarter-over-quarter to $3B.
Based on Fairpointe Capital's 13F filing for Q1 2019, filed 14 May 2019.